1. Home
  2. AXTI vs RLAY Comparison

AXTI vs RLAY Comparison

Compare AXTI & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AXT Inc

AXTI

AXT Inc

N/A

Current Price

$63.17

Market Cap

4.2B

Sector

Technology

ML Signal

N/A

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

N/A

Current Price

$18.89

Market Cap

4.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AXTI
RLAY
Founded
1986
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
4.1B
IPO Year
1998
2020

Fundamental Metrics

Financial Performance
Metric
AXTI
RLAY
Price
$63.17
$18.89
Analyst Decision
Hold
Strong Buy
Analyst Count
3
10
Target Price
$50.50
$19.50
AVG Volume (30 Days)
7.7M
2.7M
Earning Date
04-30-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
31.78
EPS
0.16
N/A
Revenue
$99,361,000.00
$15,355,000.00
Revenue This Year
$44.70
N/A
Revenue Next Year
$42.23
$324.03
P/E Ratio
$362.50
N/A
Revenue Growth
31.09
53.44
52 Week Low
$3.85
$4.05
52 Week High
$143.16
$21.27

Technical Indicators

Market Signals
Indicator
AXTI
RLAY
Relative Strength Index (RSI) 43.82 48.04
Support Level $53.06 $18.00
Resistance Level $71.49 $20.82
Average True Range (ATR) 5.06 0.70
MACD -0.65 -0.04
Stochastic Oscillator 24.74 46.76

Price Performance

Historical Comparison
AXTI
RLAY

About AXTI AXT Inc

AXT Inc is a developer and producer of compound and single element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

Share on Social Networks: